Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Company Data

Name Cardio Diagnostics Holdings Inc. - Common stock

Company Cardio Diagnostics Holdings, Inc.

Symbol CDIO

Website https://cardiodiagnosticsinc.com

Primary Exchange

NASDAQ

ISIN US14159C1036

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Meeshanthini V. Dogan

Country United States of America

Currency USD

Employees 0,0 T

Address 400 N Aberdeen St, 60642 Chicago

IPO Date 2022-01-14

Stock Splits

Date	Split
13.05.2025	1:30

ID Changes

Date	From	To
26.10.2022	MAAQ	CDIO

Ticker Symbols

Name	Symbol
NASDAQ	CDIO

More Shares

Investors who hold Cardio Diagnostics Holdings Inc. - Common stock also have the following shares in their portfolio:

Sichuan Goldstone Asia Pharmaceutical Inc. Share

VIRBAC SA ,25 Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog